Skip to content

Metlife

NYSE: MET · USD

Metlife financials

6 charts

Revenue

USD millions

$724M
Metlife Revenue. Quarterly values and changes versus the preceding comparable period. Missing values are unavailable.
PeriodRevenue
FY 2009 Q2$8,266M; Change unavailable vs FY 2009 Q1
FY 2009 Q3$10,238M; +23.9% vs FY 2009 Q2
FY 2009 Q4$12,341M; +20.5% vs FY 2009 Q3
FY 2010 Q1$13,190M; +6.9% vs FY 2009 Q4
FY 2010 Q2$14,246M; +8.0% vs FY 2010 Q1
FY 2010 Q3$12,444M; −12.6% vs FY 2010 Q2
FY 2010 Q4$12,838M; +3.2% vs FY 2010 Q3
FY 2011 Q1$15,912M; +23.9% vs FY 2010 Q4
FY 2011 Q2$17,150M; +7.8% vs FY 2011 Q1
FY 2011 Q3$20,458M; +19.3% vs FY 2011 Q2
FY 2011 Q4$16,746M; −18.1% vs FY 2011 Q3
FY 2012 Q1$15,916M; −5.0% vs FY 2011 Q4
FY 2012 Q2$18,398M; +15.6% vs FY 2012 Q1
FY 2012 Q3$16,503M; −10.3% vs FY 2012 Q2
FY 2012 Q4$17,333M; +5.0% vs FY 2012 Q3
FY 2013 Q1$17,683M; +2.0% vs FY 2012 Q4
FY 2013 Q2$15,721M; −11.1% vs FY 2013 Q1
FY 2013 Q3$16,337M; +3.9% vs FY 2013 Q2
FY 2013 Q4$18,458M; +13.0% vs FY 2013 Q3
FY 2014 Q1$17,085M; −7.4% vs FY 2013 Q4
FY 2014 Q2$18,266M; +6.9% vs FY 2014 Q1
FY 2014 Q3$18,846M; +3.2% vs FY 2014 Q2
FY 2014 Q4$19,119M; +1.4% vs FY 2014 Q3
FY 2015 Q1$18,710M; −2.1% vs FY 2014 Q4
FY 2015 Q2$16,166M; −13.6% vs FY 2015 Q1
FY 2015 Q3$18,031M; +11.5% vs FY 2015 Q2
FY 2015 Q4$17,044M; −5.5% vs FY 2015 Q3
FY 2016 Q1$18,433M; +8.1% vs FY 2015 Q4
FY 2016 Q2$15,244M; −17.3% vs FY 2016 Q1
FY 2016 Q3$17,723M; +16.3% vs FY 2016 Q2
FY 2016 Q4$12,076M; −31.9% vs FY 2016 Q3
FY 2017 Q1$16,269M; +34.7% vs FY 2016 Q4
FY 2017 Q2$17,245M; +6.0% vs FY 2017 Q1
FY 2017 Q3$16,104M; −6.6% vs FY 2017 Q2
FY 2017 Q4$15,840M; −1.6% vs FY 2017 Q3
FY 2018 Q1$14,805M; −6.5% vs FY 2017 Q4
FY 2018 Q2$21,185M; +43.1% vs FY 2018 Q1
FY 2018 Q3$16,289M; −23.1% vs FY 2018 Q2
FY 2018 Q4$15,662M; −3.8% vs FY 2018 Q3
FY 2019 Q1$337M; −97.8% vs FY 2018 Q4
FY 2019 Q2$324M; −3.9% vs FY 2019 Q1
FY 2019 Q3$313M; −3.4% vs FY 2019 Q2
FY 2019 Q4$17,143M; +5377.0% vs FY 2019 Q3
FY 2020 Q1$345M; −98.0% vs FY 2019 Q4
FY 2020 Q2$324M; −6.1% vs FY 2020 Q1
FY 2020 Q3$331M; +2.2% vs FY 2020 Q2
FY 2020 Q4$19,418M; +5766.5% vs FY 2020 Q3
FY 2021 Q1$515M; −97.3% vs FY 2020 Q4
FY 2021 Q2$514M; −0.2% vs FY 2021 Q1
FY 2021 Q3$516M; +0.4% vs FY 2021 Q2
FY 2021 Q4$529M; +2.5% vs FY 2021 Q3
FY 2022 Q1$550M; +4.0% vs FY 2021 Q4
FY 2022 Q2$525M; −4.5% vs FY 2022 Q1
FY 2022 Q3$511M; −2.7% vs FY 2022 Q2
FY 2022 Q4$15,608M; +2954.4% vs FY 2022 Q3
FY 2023 Q1$562M; −96.4% vs FY 2022 Q4
FY 2023 Q2$546M; −2.8% vs FY 2023 Q1
FY 2023 Q3$554M; +1.5% vs FY 2023 Q2
FY 2023 Q4$19,028M; +3334.7% vs FY 2023 Q3
FY 2024 Q1$577M; −97.0% vs FY 2023 Q4
FY 2024 Q2$558M; −3.3% vs FY 2024 Q1
FY 2024 Q3$554M; −0.7% vs FY 2024 Q2
FY 2024 Q4$556M; +0.4% vs FY 2024 Q3
FY 2025 Q1$611M; +9.9% vs FY 2024 Q4
FY 2025 Q2$604M; −1.1% vs FY 2025 Q1
FY 2025 Q3$621M; +2.8% vs FY 2025 Q2
FY 2025 Q4$600M; −3.4% vs FY 2025 Q3
FY 2026 Q1$734M; +22.3% vs FY 2025 Q4
FY 2026 Q2$724M; −1.4% vs FY 2026 Q1
Jun 30, 2009 through Sep 25, 2026

Net income

USD millions

$736M
Metlife Net income. Quarterly values and changes versus the preceding comparable period. Missing values are unavailable.
PeriodNet income
FY 2009 Q2$-1,402M; Change unavailable vs FY 2009 Q1
FY 2009 Q3$-620M; +55.8% vs FY 2009 Q2
FY 2009 Q4$320M; +151.6% vs FY 2009 Q3
FY 2010 Q1$835M; +160.9% vs FY 2009 Q4
FY 2010 Q2$1,557M; +86.5% vs FY 2010 Q1
FY 2010 Q3$316M; −79.7% vs FY 2010 Q2
FY 2010 Q4$82M; −74.1% vs FY 2010 Q3
FY 2011 Q1$1,006M; +1126.8% vs FY 2010 Q4
FY 2011 Q2$1,237M; +23.0% vs FY 2011 Q1
FY 2011 Q3$3,582M; +189.6% vs FY 2011 Q2
FY 2011 Q4$1,156M; −67.7% vs FY 2011 Q3
FY 2012 Q1$-144M; −112.5% vs FY 2011 Q4
FY 2012 Q2$2,295M; +1693.8% vs FY 2012 Q1
FY 2012 Q3$-954M; −141.6% vs FY 2012 Q2
FY 2012 Q4$127M; +113.3% vs FY 2012 Q3
FY 2013 Q1$986M; +676.4% vs FY 2012 Q4
FY 2013 Q2$502M; −49.1% vs FY 2013 Q1
FY 2013 Q3$972M; +93.6% vs FY 2013 Q2
FY 2013 Q4$908M; −6.6% vs FY 2013 Q3
FY 2014 Q1$1,328M; +46.3% vs FY 2013 Q4
FY 2014 Q2$1,366M; +2.9% vs FY 2014 Q1
FY 2014 Q3$2,094M; +53.3% vs FY 2014 Q2
FY 2014 Q4$1,521M; −27.4% vs FY 2014 Q3
FY 2015 Q1$2,158M; +41.9% vs FY 2014 Q4
FY 2015 Q2$1,115M; −48.3% vs FY 2015 Q1
FY 2015 Q3$1,203M; +7.9% vs FY 2015 Q2
FY 2015 Q4$834M; −30.7% vs FY 2015 Q3
FY 2016 Q1$2,201M; +163.9% vs FY 2015 Q4
FY 2016 Q2$110M; −95.0% vs FY 2016 Q1
FY 2016 Q3$577M; +424.5% vs FY 2016 Q2
FY 2016 Q4$-2,088M; −461.9% vs FY 2016 Q3
FY 2017 Q1$826M; +139.6% vs FY 2016 Q4
FY 2017 Q2$884M; +7.0% vs FY 2017 Q1
FY 2017 Q3$-81M; −109.2% vs FY 2017 Q2
FY 2017 Q4$2,317M; +2960.5% vs FY 2017 Q3
FY 2018 Q1$1,253M; −45.9% vs FY 2017 Q4
FY 2018 Q2$891M; −28.9% vs FY 2018 Q1
FY 2018 Q3$912M; +2.4% vs FY 2018 Q2
FY 2018 Q4$2,067M; +126.6% vs FY 2018 Q3
FY 2019 Q1$1,381M; −33.2% vs FY 2018 Q4
FY 2019 Q2$1,741M; +26.1% vs FY 2019 Q1
FY 2019 Q3$2,184M; +25.4% vs FY 2019 Q2
FY 2019 Q4$593M; −72.8% vs FY 2019 Q3
FY 2020 Q1$4,398M; +641.7% vs FY 2019 Q4
FY 2020 Q2$145M; −96.7% vs FY 2020 Q1
FY 2020 Q3$706M; +386.9% vs FY 2020 Q2
FY 2020 Q4$158M; −77.6% vs FY 2020 Q3
FY 2021 Q1$358M; +126.6% vs FY 2020 Q4
FY 2021 Q2$3,407M; +851.7% vs FY 2021 Q1
FY 2021 Q3$1,584M; −53.5% vs FY 2021 Q2
FY 2021 Q4$1,205M; −23.9% vs FY 2021 Q3
FY 2022 Q1$669M; −44.5% vs FY 2021 Q4
FY 2022 Q2$132M; −80.3% vs FY 2022 Q1
FY 2022 Q3$395M; +199.2% vs FY 2022 Q2
FY 2022 Q4$1,578M; +299.5% vs FY 2022 Q3
FY 2023 Q1$80M; −94.9% vs FY 2022 Q4
FY 2023 Q2$402M; +402.5% vs FY 2023 Q1
FY 2023 Q3$489M; +21.6% vs FY 2023 Q2
FY 2023 Q4$607M; +24.1% vs FY 2023 Q3
FY 2024 Q1$867M; +42.8% vs FY 2023 Q4
FY 2024 Q2$946M; +9.1% vs FY 2024 Q1
FY 2024 Q3$1,342M; +41.9% vs FY 2024 Q2
FY 2024 Q4$1,271M; −5.3% vs FY 2024 Q3
FY 2025 Q1$945M; −25.6% vs FY 2024 Q4
FY 2025 Q2$729M; −22.9% vs FY 2025 Q1
FY 2025 Q3$896M; +22.9% vs FY 2025 Q2
FY 2025 Q4$809M; −9.7% vs FY 2025 Q3
FY 2026 Q1$1,185M; +46.5% vs FY 2025 Q4
FY 2026 Q2$736M; −37.9% vs FY 2026 Q1

Net margin

%

101.66%
Metlife Net margin. Reported fiscal history.
Fiscal period%
FY 2009 Q2-16.96%
FY 2009 Q3-6.06%
FY 2009 Q42.59%
FY 2010 Q16.33%
FY 2010 Q210.93%
FY 2010 Q32.54%
FY 2010 Q40.64%
FY 2011 Q16.32%
FY 2011 Q27.21%
FY 2011 Q317.51%
FY 2011 Q46.9%
FY 2012 Q1-0.9%
FY 2012 Q212.47%
FY 2012 Q3-5.78%
FY 2012 Q40.73%
FY 2013 Q15.58%
FY 2013 Q23.19%
FY 2013 Q35.95%
FY 2013 Q44.92%
FY 2014 Q17.77%
FY 2014 Q27.48%
FY 2014 Q311.11%
FY 2014 Q47.96%
FY 2015 Q111.53%
FY 2015 Q26.9%
FY 2015 Q36.67%
FY 2015 Q44.89%
FY 2016 Q111.94%
FY 2016 Q20.72%
FY 2016 Q33.26%
FY 2016 Q4-17.29%
FY 2017 Q15.08%
FY 2017 Q25.13%
FY 2017 Q3-0.5%
FY 2017 Q414.63%
FY 2018 Q18.46%
FY 2018 Q24.21%
FY 2018 Q35.6%
FY 2018 Q413.2%
FY 2019 Q1409.79%
FY 2019 Q2537.35%
FY 2019 Q3697.76%
FY 2019 Q43.46%
FY 2020 Q11,274.78%
FY 2020 Q244.75%
FY 2020 Q3213.29%
FY 2020 Q40.81%
FY 2021 Q169.51%
FY 2021 Q2662.84%
FY 2021 Q3306.98%
FY 2021 Q4227.79%
FY 2022 Q1121.64%
FY 2022 Q225.14%
FY 2022 Q377.3%
FY 2022 Q410.11%
FY 2023 Q114.23%
FY 2023 Q273.63%
FY 2023 Q388.27%
FY 2023 Q43.19%
FY 2024 Q1150.26%
FY 2024 Q2169.53%
FY 2024 Q3242.24%
FY 2024 Q4228.6%
FY 2025 Q1154.66%
FY 2025 Q2120.7%
FY 2025 Q3144.28%
FY 2025 Q4134.83%
FY 2026 Q1161.44%
FY 2026 Q2101.66%

P/E

× · TTM · Daily

18.37×
Metlife P/E. Monthly closing observations; inspect daily values with the chart arrow keys.
Close date× · TTM · DailyFinancials through
2012-02-2911.71×2010-09-30
2012-03-3011.35×2010-09-30
2012-04-3010.95×2010-09-30
2012-05-318.88×2010-09-30
2012-06-299.37×2010-09-30
2012-07-319.35×2010-09-30
2012-08-3110.37×2010-09-30
2012-09-2810.47×2010-09-30
2012-10-3110.79×2010-09-30
2012-11-3010.09×2010-09-30
2012-12-3110.01×2010-09-30
2013-01-3111.35×2010-09-30
2013-02-2832.35×2012-12-31
2013-03-2834.71×2012-12-31
2013-04-3035.6×2012-12-31
2013-05-3120.93×2013-03-31
2013-06-2821.66×2013-03-31
2013-07-3122.92×2013-03-31
2013-08-3094.84×2013-06-30
2013-09-3096.4×2013-06-30
2013-10-3197.14×2013-06-30
2013-11-2923.66×2013-09-30
2013-12-3124.44×2013-09-30
2014-01-3122.23×2013-09-30
2014-02-2817.76×2013-12-31
2014-03-3118.51×2013-12-31
2014-04-3018.35×2013-12-31
2014-05-3016.19×2014-03-31
2014-06-3017.66×2014-03-31
2014-07-3116.72×2014-03-31
2014-08-2914.04×2014-06-30
2014-09-3013.78×2014-06-30
2014-10-3113.92×2014-06-30
2014-11-2811.38×2014-09-30
2014-12-3111.07×2014-09-30
2015-01-309.52×2014-09-30
2015-02-2710.41×2014-09-30
2015-03-319.37×2014-12-31
2015-04-309.51×2014-12-31
2015-05-298.46×2015-03-31
2015-06-309.06×2015-03-31
2015-07-319.02×2015-03-31
2015-08-318.41×2015-06-30
2015-09-307.91×2015-06-30
2015-10-308.45×2015-06-30
2015-11-309.86×2015-09-30
2015-12-319.3×2015-09-30
2016-01-298.61×2015-09-30
2016-02-298.61×2015-12-31
2016-03-319.56×2015-12-31
2016-04-299.82×2015-12-31
2016-05-319.68×2016-03-31
2016-06-308.46×2016-03-31
2016-07-299.08×2016-03-31
2016-08-3111.35×2016-06-30
2016-09-3011.62×2016-06-30
2016-10-3112.28×2016-06-30
2016-11-3016.88×2016-09-30
2016-12-3016.54×2016-09-30
2017-01-3116.7×2016-09-30
2017-02-2816.09×2016-09-30
2017-03-3183.89×2016-12-31
2017-04-2882.29×2016-12-31
2017-05-31—2017-03-31
2017-06-30—2017-03-31
2017-07-31—2017-03-31
2017-08-31592.26×2017-06-30
2017-09-29657.01×2017-06-30
2017-10-31677.63×2017-06-30
2017-11-30—2017-09-30
2017-12-29—2017-09-30
2018-01-31—2017-09-30
2018-02-28—2017-09-30
2018-03-2912.48×2017-12-31
2018-04-3012.96×2017-12-31
2018-05-3111.25×2018-03-31
2018-06-2910.66×2018-03-31
2018-07-3111.19×2018-03-31
2018-08-3110.98×2018-06-30
2018-09-2811.18×2018-06-30
2018-10-319.86×2018-06-30
2018-11-308.52×2018-09-30
2018-12-317.84×2018-09-30
2019-01-318.72×2018-09-30
2019-02-288.96×2018-12-31
2019-03-298.44×2018-12-31
2019-04-309.14×2018-12-31
2019-05-318.76×2019-03-31
2019-06-289.41×2019-03-31
2019-07-319.36×2019-03-31
2019-08-307.13×2019-06-30
2019-09-307.59×2019-06-30
2019-10-317.53×2019-06-30
2019-11-296.5×2019-09-30
2019-12-316.63×2019-09-30
2020-01-316.47×2019-09-30
2020-02-286.91×2019-12-31
2020-03-314.94×2019-12-31
2020-04-305.84×2019-12-31
2020-05-293.79×2020-03-31
2020-06-303.85×2020-03-31
2020-07-313.99×2020-03-31
2020-08-314.93×2020-06-30
2020-09-304.77×2020-06-30
2020-10-304.85×2020-06-30
2020-11-307.53×2020-09-30
2020-12-317.66×2020-09-30
2021-01-297.85×2020-09-30
2021-02-2610.05×2020-12-31
2021-03-3110.61×2020-12-31
2021-04-3011.11×2020-12-31
2021-05-2852.29×2021-03-31
2021-06-3047.89×2021-03-31
2021-07-3046.17×2021-03-31
2021-08-3112.36×2021-06-30
2021-09-3012.31×2021-06-30
2021-10-2912.52×2021-06-30
2021-11-309.53×2021-09-30
2021-12-3110.15×2021-09-30
2022-01-3110.89×2021-09-30
2022-02-288.99×2021-12-31
2022-03-319.35×2021-12-31
2022-04-298.74×2021-12-31
2022-05-318.39×2022-03-31
2022-06-307.82×2022-03-31
2022-07-297.88×2022-03-31
2022-08-3115.38×2022-06-30
2022-09-3014.53×2022-06-30
2022-10-3117.51×2022-06-30
2022-11-3027.71×2022-09-30
2022-12-3026.15×2022-09-30
2023-01-3126.38×2022-09-30
2023-02-2825.92×2022-09-30
2023-03-3120.94×2022-09-30
2023-04-2822.16×2022-09-30
2023-05-3117.9×2022-09-30
2023-06-3020.43×2022-09-30
2023-07-3122.75×2022-09-30
2023-08-3122.89×2022-09-30
2023-09-2922.73×2022-09-30
2023-10-3121.68×2022-09-30
2023-11-3022.99×2022-09-30
2023-12-2923.89×2022-09-30
2024-01-3125.05×2022-09-30
2024-02-2925.2×2022-09-30
2024-03-2826.78×2022-09-30
2024-04-3025.68×2022-09-30
2024-05-3126.15×2022-09-30
2024-06-2825.36×2022-09-30
2024-07-3127.77×2022-09-30
2024-08-3028×2022-09-30
2024-09-3029.8×2022-09-30
2024-10-3128.34×2022-09-30
2024-11-2931.88×2022-09-30
2024-12-3129.59×2022-09-30
2025-01-3131.26×2022-09-30
2025-02-2814.23×2024-12-31
2025-03-3113.26×2024-12-31
2025-04-3012.45×2024-12-31
2025-05-3012.98×2024-12-31
2025-06-3013.28×2024-12-31
2025-07-3112.54×2024-12-31
2025-08-2913.44×2024-12-31
2025-09-3013.6×2024-12-31
2025-10-3113.18×2024-12-31
2025-11-2814.1×2025-09-30
2025-12-3114.53×2025-09-30
2026-01-3014.52×2025-09-30
2026-02-2715.04×2025-12-31
2026-03-3114.76×2025-12-31
2026-04-3016.72×2025-12-31
2026-05-2915.79×2026-03-31
2026-06-3016.16×2026-03-31
2026-07-3118.36×2026-03-31
2026-08-3117.89×2026-06-30
2026-09-2518.37×2026-06-30
Mean 28.83×Median 12.49×47% above median

ROE

% · Annual / TTM

12.48%
Metlife ROE. Reported fiscal history.
Fiscal period% · Annual / TTM
FY 2009 Q2—
FY 2009 Q3—
FY 2009 Q4—
FY 2010 Q1—
FY 2010 Q25.91%
FY 2010 Q37.2%
FY 2010 Q46.53%
FY 2011 Q16.29%
FY 2011 Q25.12%
FY 2011 Q310.56%
FY 2011 Q412.38%
FY 2012 Q110.53%
FY 2012 Q211.7%
FY 2012 Q33.59%
FY 2012 Q41.93%
FY 2013 Q13.79%
FY 2013 Q20.88%
FY 2013 Q33.94%
FY 2013 Q45.15%
FY 2014 Q15.51%
FY 2014 Q26.87%
FY 2014 Q38.46%
FY 2014 Q49.26%
FY 2015 Q110.06%
FY 2015 Q29.68%
FY 2015 Q38.29%
FY 2015 Q47.36%
FY 2016 Q16.98%
FY 2016 Q25.71%
FY 2016 Q34.86%
FY 2016 Q41.03%
FY 2017 Q1-0.94%
FY 2017 Q20.13%
FY 2017 Q3-0.83%
FY 2017 Q46.2%
FY 2018 Q16.87%
FY 2018 Q26.95%
FY 2018 Q39.68%
FY 2018 Q48.94%
FY 2019 Q18.86%
FY 2019 Q210.09%
FY 2019 Q311.99%
FY 2019 Q49.62%
FY 2020 Q113.58%
FY 2020 Q210.21%
FY 2020 Q37.91%
FY 2020 Q47.38%
FY 2021 Q11.64%
FY 2021 Q26.09%
FY 2021 Q37.45%
FY 2021 Q48.95%
FY 2022 Q111.13%
FY 2022 Q26.41%
FY 2022 Q34.71%
FY 2022 Q44.98%
FY 2023 Q14.64%
FY 2023 Q26.72%
FY 2023 Q39.28%
FY 2023 Q44.84%
FY 2024 Q17.13%
FY 2024 Q29.42%
FY 2024 Q312.6%
FY 2024 Q414.71%
FY 2025 Q115.37%
FY 2025 Q214.89%
FY 2025 Q312.15%
FY 2025 Q411.36%
FY 2026 Q112.53%
FY 2026 Q212.48%

Capital allocation

% of tracked cash uses

$1,105M
Metlife capital allocation. Quarterly values. Missing values are unavailable.
PeriodCapexAcquisitionsBuybacksDividendsDebt repaymentsTracked uses
FY 2009 Q2UnavailableUnavailableUnavailableUnavailable100% · $22M100% · $22M
FY 2009 Q3Unavailable0% · $0M0% · $0MUnavailable100% · $110M100% · $110M
FY 2009 Q4Unavailable0% · $0M0% · $0MUnavailable100% · $311M100% · $311M
FY 2010 Q1UnavailableUnavailableUnavailableUnavailable100% · $322M100% · $322M
FY 2010 Q2UnavailableUnavailableUnavailableUnavailable100% · $189M100% · $189M
FY 2010 Q3UnavailableUnavailableUnavailableUnavailable100% · $178M100% · $178M
FY 2010 Q4UnavailableUnavailableUnavailableUnavailable100% · $372M100% · $372M
FY 2011 Q1UnavailableUnavailableUnavailableUnavailable100% · $249M100% · $249M
FY 2011 Q2UnavailableUnavailableUnavailableUnavailable100% · $466M100% · $466M
FY 2011 Q3UnavailableUnavailableUnavailableUnavailable100% · $477M100% · $477M
FY 2011 Q4UnavailableUnavailableUnavailableUnavailable100% · $850M100% · $850M
FY 2012 Q1UnavailableUnavailableUnavailable0% · $0M100% · $349M100% · $349M
FY 2012 Q2UnavailableUnavailableUnavailable0% · $0M100% · $673M100% · $673M
FY 2012 Q3UnavailableUnavailableUnavailable0% · $0M100% · $84M100% · $84M
FY 2012 Q4UnavailableUnavailableUnavailable57.64% · $811M42.36% · $596M100% · $1,407M
FY 2013 Q1UnavailableUnavailableUnavailable45.82% · $203M54.18% · $240M100% · $443M
FY 2013 Q2UnavailableUnavailableUnavailable72.25% · $302M27.75% · $116M100% · $418M
FY 2013 Q3UnavailableUnavailable0% · $0M42.56% · $303M57.44% · $409M100% · $712M
FY 2013 Q4UnavailableUnavailable0% · $0M24.07% · $311M75.93% · $981M100% · $1,292M
FY 2014 Q1UnavailableUnavailable0% · $0M17.56% · $311M82.44% · $1,460M100% · $1,771M
FY 2014 Q2UnavailableUnavailable0.28% · $4M27.76% · $395M71.96% · $1,024M100% · $1,423M
FY 2014 Q3UnavailableUnavailable38.11% · $439M34.29% · $395M27.6% · $318M100% · $1,152M
FY 2014 Q4UnavailableUnavailable54.88% · $557M39.21% · $398M5.91% · $60M100% · $1,015M
FY 2015 Q1UnavailableUnavailable71.09% · $986M28.41% · $394M0.5% · $7M100% · $1,387M
FY 2015 Q2UnavailableUnavailable0.97% · $14M29.03% · $420M70.01% · $1,013M100% · $1,447M
FY 2015 Q3UnavailableUnavailable18.29% · $107M71.79% · $420M9.91% · $58M100% · $585M
FY 2015 Q4UnavailableUnavailable51.37% · $823M26.15% · $419M22.47% · $360M100% · $1,602M
FY 2016 Q1UnavailableUnavailable14.34% · $70M84.63% · $413M1.02% · $5M100% · $488M
FY 2016 Q2UnavailableUnavailable0% · $0M25.94% · $441M74.06% · $1,259M100% · $1,700M
FY 2016 Q3UnavailableUnavailable0% · $0M98% · $441M2% · $9M100% · $450M
FY 2016 Q4Unavailable0% · $0M40.32% · $302M58.88% · $441M0.8% · $6M100% · $749M
FY 2017 Q1UnavailableUnavailable66.05% · $858M33.64% · $437M0.31% · $4M100% · $1,299M
FY 2017 Q2UnavailableUnavailable68.59% · $952M31.05% · $431M0.36% · $5M100% · $1,388M
FY 2017 Q3UnavailableUnavailable50.87% · $495M43.88% · $427M5.24% · $51M100% · $973M
FY 2017 Q4Unavailable0% · $0M30.24% · $622M20.52% · $422M49.25% · $1,013M100% · $2,057M
FY 2018 Q1UnavailableUnavailable69.91% · $1,041M27.94% · $416M2.15% · $32M100% · $1,489M
FY 2018 Q2UnavailableUnavailable65.17% · $1,115M25.01% · $428M9.82% · $168M100% · $1,711M
FY 2018 Q3UnavailableUnavailable29.36% · $636M19.34% · $419M51.29% · $1,111M100% · $2,166M
FY 2018 Q4Unavailable0% · $0M55.17% · $1,200M19.08% · $415M25.75% · $560M100% · $2,175M
FY 2019 Q1UnavailableUnavailable54.64% · $500M44.26% · $405M1.09% · $10M100% · $915M
FY 2019 Q2UnavailableUnavailable36.51% · $750M20.4% · $419M43.09% · $885M100% · $2,054M
FY 2019 Q3UnavailableUnavailable65.2% · $785M34.3% · $413M0.5% · $6M100% · $1,204M
FY 2019 Q4UnavailableUnavailable37.82% · $250M61.42% · $406M0.76% · $5M100% · $661M
FY 2020 Q1UnavailableUnavailable54.95% · $500M44.4% · $404M0.66% · $6M100% · $910M
FY 2020 Q2UnavailableUnavailable0% · $0M100% · $419MUnavailable100% · $419M
FY 2020 Q3UnavailableUnavailable16.03% · $80M83.97% · $419MUnavailable100% · $499M
FY 2020 Q4UnavailableUnavailable57.91% · $571M42.09% · $415MUnavailable100% · $986M
FY 2021 Q1UnavailableUnavailable71% · $999M29% · $408MUnavailable100% · $1,407M
FY 2021 Q2UnavailableUnavailable72.56% · $1,113M27.44% · $421MUnavailable100% · $1,534M
FY 2021 Q3UnavailableUnavailable71.08% · $1,015M28.92% · $413MUnavailable100% · $1,428M
FY 2021 Q4UnavailableUnavailable74.38% · $1,176M25.62% · $405MUnavailable100% · $1,581M
FY 2022 Q1UnavailableUnavailable70.31% · $940M29.69% · $397MUnavailable100% · $1,337M
FY 2022 Q2UnavailableUnavailable73.23% · $1,116M26.77% · $408MUnavailable100% · $1,524M
FY 2022 Q3UnavailableUnavailable62.76% · $674M37.24% · $400MUnavailable100% · $1,074M
FY 2022 Q4UnavailableUnavailable60.26% · $596M39.74% · $393MUnavailable100% · $989M
FY 2023 Q1UnavailableUnavailable66.72% · $780M33.28% · $389MUnavailable100% · $1,169M
FY 2023 Q2UnavailableUnavailable62.75% · $672M37.25% · $399MUnavailable100% · $1,071M
FY 2023 Q3UnavailableUnavailable66.89% · $792M33.11% · $392MUnavailable100% · $1,184M
FY 2023 Q4UnavailableUnavailable69% · $859M31% · $386MUnavailable100% · $1,245M
FY 2024 Q1UnavailableUnavailable75.66% · $1,172M24.34% · $377MUnavailable100% · $1,549M
FY 2024 Q2UnavailableUnavailable68.73% · $855M31.27% · $389MUnavailable100% · $1,244M
FY 2024 Q3UnavailableUnavailable66.9% · $774M33.1% · $383MUnavailable100% · $1,157M
FY 2024 Q4UnavailableUnavailable51.79% · $406M48.21% · $378MUnavailable100% · $784M
FY 2025 Q1UnavailableUnavailable79.05% · $1,411M20.95% · $374MUnavailable100% · $1,785M
FY 2025 Q2UnavailableUnavailable57.17% · $510M42.83% · $382MUnavailable100% · $892M
FY 2025 Q3UnavailableUnavailable57.05% · $502M42.95% · $378MUnavailable100% · $880M
FY 2025 Q4UnavailableUnavailable55.09% · $460M44.91% · $375MUnavailable100% · $835M
FY 2026 Q1UnavailableUnavailable66.99% · $755M33.01% · $372MUnavailable100% · $1,127M
FY 2026 Q2UnavailableUnavailable65.34% · $722M34.66% · $383MUnavailable100% · $1,105M

Tracked cash uses · SBC excluded

Sources and calculations

Company filings · USD · Last checked 2026-10-18. Missing inputs remain unavailable. Your chart selection and layout are saved in this browser for Metlife.

All charts share the selected dates. Quarterly/Yearly changes fiscal charts; valuation keeps completed daily closes on a published TTM basis. Later restatements can delay that basis. Historical mean, median and pricing labels use the selected range and do not estimate intrinsic fair value.

Revenue
Reported revenue from company filings.
Net income
Reported company figures.
Net margin
Reported net income / revenue × 100.
P/E
Completed closing price × diluted shares / TTM earnings attributable to common shareholders.
ROE
Earnings attributable to owners / average equity attributable to owners × 100, using period end and one year earlier.
Capital allocation
Reported cash uses as a percentage of tracked uses. Missing categories remain unavailable; SBC is noncash and excluded.
Reported revenue and sources